Search results

Back
1 - 10 of 301 Search results
15 October 2025

15 October 2025

Partnering

We leverage our agility, R&D capabilities and global footprint to develop valuable business partnerships that fuel tomorrow’s breakthrough discoveries across our three therapeutic areas: Oncology, Rare Disease, and Neuroscience. External innovation i...

19 March 2026  - 2 mins read

19 March 2026  - 2 mins read

Purpose‑driven partnering: choosing programs where our approach makes the greatest impact

Nick Gagnon, Vice President and Head of Late Stage Partnering...

19 March 2026  - 2 mins read

19 March 2026  - 2 mins read

Partenariats guidés par la raison d’être : choisir les programmes où notre approche génère le plus grand impact

Nick Gagnon, Vice-Président et Responsable des Partenariats en Phase Avancée...

19 September 2025  - 2 mins read

19 September 2025  - 2 mins read

Pharma Partnerships Thrive by Celebrating Every Milestone Along the Journey

...

19 September 2025  - 3 mins read

19 September 2025  - 3 mins read

Les partenariats pharmaceutiques prospèrent en célébrant chaque étape du parcours

...

08 June 2026  - 2 mins read

08 June 2026  - 2 mins read

Biopharma deals thrive on creativity, from structure through to execution  

Philippe Lopes‑Fernandes, Chief Business Officer  ...

05 June 2026  - 2 mins read

05 June 2026  - 2 mins read

World Environment Day: Acting where it matters most

...

12 September 2024  - 4 mins read

12 September 2024  - 4 mins read

Partnering for Progress: The Importance of Collaboration in Primary Biliary Cholangitis (PBC) Awareness  

Sandra Silvestri, Executive Vice President & Chief Medical Officer at Ipsen, reflects on the theme for this year’s PBC Awareness Day, what living with PBC really means, and the power of collaborating with patient organizations to help drive progress ...

28 October 2024  - 2 mins read

28 October 2024  - 2 mins read

Science-First Collaborations: Ipsen’s Blueprint to External Innovation

David Jenkins, SVP and Head of External Innovation and Research, leads efforts to identify, evaluate and secure new programs across Ipsen’s three strategic areas of Oncology, Rare disease, and Neuroscience. He shares his insights on the essential role th...

28 October 2024  - 3 mins read

28 October 2024  - 3 mins read

Collaborations scientifiques : le modèle d’Ipsen en matière d’innovation externe

David Jenkins, Vice-Président Senior, à la tête du département Recherche & Innovation Externe, est responsable des activités visant à identifier, évaluer et ajouter au portefeuille d’Ipsen de nouveaux programmes dans les trois aires thérapeut...

1 2 3 … 31